Entero Therapeutics, Inc. Common Stock (ENTO) EBITDA (2024 - 2025)
Entero Therapeutics, Inc. Common Stock (ENTO) EBITDA from Jun 30, 2024 to Sep 30, 2025. The TTM Entero Therapeutics, Inc. Common Stock (ENTO) EBITDA is -$3.59M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Entero Therapeutics, Inc. Common Stock (ENTO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -32.01% |
Annual EBITDA change of Entero Therapeutics, Inc. Common Stock (ENTO)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$2.39M | -84.65% |
| 2024 | -$16M | N/A |